Rang	Name	Position
1	Mr. Matthew Pauls J.D., M.B.A.	Chairman & CEO
2	Mr. Robert Matthew Lutz M.B.A.	COO & CFO
3	Dr. Yasmine Wasfi M.D., Ph.D.	Chief Medical Officer
4	Ms. Kate McCabe J.D.	Chief Legal Officer
5	Ms. Megan Carpenter	Chief People Officer
6	Ms. Anne Erickson	Chief Business & Corporate Affairs Officer
7	Brian Maurer	Head of Clinical Operations
8	Mr. Charles LaPree	Executive VP & Head of Global Regulatory Affairs
9	Dr. Brian Robinson M.D.	Executive Vice President of Global Medical Affairs
10	Dr. Siddharth J. Advant Ph.D.	Executive Vice President of Global Technical Operations

Aufteilung der Investoren

Rang	Inhaber	Anteile	Wert
1	NEA Management Company, LLC	11,91%	0,13 Mrd. USD
2	Bain Capital Life Sciences Investors, LLC	8,57%	0,10 Mrd. USD
3	VR Adviser, LLC	6,69%	0,08 Mrd. USD
4	Deerfield Management Co	6,61%	0,07 Mrd. USD
5	TCG Crossover Management, LLC	6,02%	0,07 Mrd. USD
6	BlackRock Inc	5,50%	0,06 Mrd. USD
7	Frazier Life Sciences Management, L.P.	4,73%	0,05 Mrd. USD
8	Polar Capital Holdings PLC	4,65%	0,05 Mrd. USD
9	Vanguard Capital Management, LLC	3,79%	0,04 Mrd. USD
10	Nantahala Capital Management, LLC	3,58%	0,04 Mrd. USD
11	State Street Corp	3,27%	0,04 Mrd. USD
12	RTW INVESTMENTS, LLC	2,90%	0,03 Mrd. USD
13	Marshall Wace Asset Management Ltd	2,20%	0,03 Mrd. USD
14	Woodline Partners LP	2,07%	0,02 Mrd. USD
15	Geode Capital Management, LLC	1,75%	0,02 Mrd. USD
16	Spruce Street Capital LP	1,68%	0,02 Mrd. USD
17	Rosalind Advisors, Inc.	1,56%	0,02 Mrd. USD
18	Emerald Advisers, LLC	1,53%	0,02 Mrd. USD
19	Pictet Asset Manangement SA	1,35%	0,02 Mrd. USD
20	Wellington Management Company LLP	1,31%	0,02 Mrd. USD